查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年 G 蛋白偶聯受體 (GPCR) 市場預測：按產品類型、檢測類型、應用和地區進行的全球分析
市場調查報告書
商品編碼
1372012

到 2030 年 G 蛋白偶聯受體 (GPCR) 市場預測：按產品類型、檢測類型、應用和地區進行的全球分析

G-Protein Coupled Receptors Market Forecasts to 2030 - Global Analysis By Product, By Assay Type, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球G蛋白偶聯受體（GPCR）市場規模將達到37億美元，並在預測期內以7.1%的年複合成長率成長，到2030年將達到59.8億美元。

稱為 G 蛋白偶聯受體 (GPCR) 的多種膜受體也稱為 7（透過）跨膜受體。它們存在於細胞膜中，負責與外部化學物質相互作用並將訊號傳遞給細胞內分子。 GPCR 是細胞表面受體，可作為以勝胜肽、蛋白質、光能、脂質和糖等形式傳遞的訊息的收件匣。這些受體經常用於治療多種疾病，包括發炎疾病、代謝紊亂、心臟疾病、癌症和單一疾病。

根據 2021 年《美國心臟協會雜誌》報道，預計到 2035 年，美國將有超過 1.3 億成年人患有某種形式的心臟病。

慢性病增加

慢性病的增加是 G 蛋白偶聯受體 (GPCR) 市場的強大促進因素。 GPCR 在許多生理過程的調節中發揮著至關重要的作用，使其成為有價值的藥物研發標靶。隨著糖尿病、心血管疾病和神經退化性疾病等慢性病的全球負擔日益加重，針對 GPCR 的藥物干涉措施的需求不斷成長。研究人員正在探索 GPCR 來尋找創新治療方法，這正在刺激製藥業的研究和開發。

G蛋白偶聯受體（GPCR）細胞株價格高昂

G蛋白偶聯受體（GPCR）細胞株的高價格是GPCR市場的主要抑制因素。取得這些細胞株的高昂成本讓小型研究機構和生物技術新興企業望而卻步，限制了他們從事 GPCR 相關研究和藥物開發的能力。這種定價障礙會抑制創新、減少競爭、阻礙理解和標靶化GPCR 的科學進展，並減緩新藥的發現。

GPCR 在藥物研發的全球普及

G 蛋白偶聯受體 (GPCR) 在藥物研發中的廣泛採用代表著市場的重大機會。 GPCR 是涉及多種生理過程調節的多種藥物標靶，對於藥物研究至關重要。由於其多樣性和參與許多疾病，包括癌症、神經系統疾病和代謝疾病，它越來越受到人們的關注。隨著藥物研發研究日益全球化，GPCR 代表了創新藥物開發的一種有前途的工具。採用 GPCR 作為新療法的標靶正在加強研究和開發配合措施，為新藥鋪平道路，並增加 GPCR 市場全球顯著成長的潛力。

GPCR 訊號系統的複雜性

被稱為 GPCR 的細胞表面受體家族包括許多不同類型的受體，並具有複雜的訊號傳導系統。要了解 GPCR 如何與各種配體和下游訊號級聯相互作用很困難，這使得新藥的發現和現有藥物的開發變得更加困難。這種複雜性使得預測候選藥物的有效性變得困難，並增加了意外不良反應的風險。此外，它需要大量的研究、最尖端科技和協作研究，這是昂貴且耗時的。所有這些因素預計將抑制市場成長。

COVID-19 的影響：

G蛋白偶聯受體（GPCR）市場在不同方面受到了COVID-19大大流行的顯著影響。由於實驗室關閉以及資源重新分配給大流行相關研究，對藥物研發至關重要的 GPCR 研究已經陷入停滯。另一方面，迫切需要引入計算科學方法和虛擬篩選方法來進行GPCR藥物研發。由於 GPCR 在免疫反應中發揮的作用及其在治療病毒感染疾病的潛力，市場對針對 GPCR 的治療藥物的需求不斷增加。總體而言，疫情影響了 GPCR 市場，透過轉向數位方法推動創新並抑制創新。

cAMP 功能檢測部分預計將成為預測期內最大的部分

cAMP 功能分析領域預計將在預測期內佔據最大的市場佔有率。 cAMP 檢測廣泛用於研究 GPCR 活化和訊號途徑，對於識別潛在候選藥物至關重要。 cAMP 測定使研究人員能夠評估 GPCR 對配體的反應，為藥物功效和安全性提供有價值的見解。隨著針對 GPCR 的藥物需求的增加，cAMP 檢測越來越受到關注，並增強了其在市場上的主導地位。

預測期內複合年複合成長率最高的癌症研究領域

由於 GPCR 在癌症進展中發揮的關鍵作用，癌症研究領域在預測期內呈現最高的成長率。研究表明，GPCR 參與腫瘤生長、血管生成和轉移，使其成為癌症治療的有吸引力的標靶。此外，對個人化醫療的日益重視以及針對 GPCR 的抗癌藥物的開發也支持了新興市場的成長。隨著對癌症中 GPCR 訊號傳導的了解不斷深入，創新治療方法不斷湧現，對 GPCR 相關研究工具的需求也隨之增加。

佔比最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，其中以美國、加拿大和墨西哥等經濟和技術先進國家為首。據美國癌症協會稱，2022 年，僅美國就會新增 190 萬癌症病例，並有 609,360 例癌症相關死亡。同樣，2021 年加拿大癌症統計數據顯示，大約五分之二的加拿大人在其一生中將被診斷出患有癌症，四分之一的人將死於該疾病。進一步推動北美市場成長的是慢性疾病的負擔，特別是心血管疾病和癌症，這推動了對尖端療法和治療的需求。

複合年複合成長率最高的地區：

由於 NB Health Laboratory、HD Biosciences Co.Ltd.、Sosei Heptares 等許多年輕公司的存在，預計亞太地區在預測期內將出現最高的成長。區域成長受到公司為擴大市場佔有率而採取的一系列配合措施的影響。此外，文明病的日益普及以及中國、印度和其他經濟體不斷成長的人口對受體介導治療的需求也將推動區域擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭關係

第5章 全球G 蛋白偶聯受體 (GPCR) 市場：按產品

  • 細胞培養試劑
  • 細胞株
  • 檢測試劑盒
  • 配體

第6章 全球G 蛋白偶聯受體 (GPCR) 市場：依檢測類型

  • cAMP功能測定
  • 鈣功能測定
  • 內化分析
  • 放射性配體結合和 GTPγS 功能測定
  • 人口販賣分析
  • B-抑制蛋白功能測定
  • 其他檢測類型

第7章 全球G 蛋白偶聯受體 (GPCR) 市場：依應用分類

  • 癌症研究
  • 心血管研究
  • 中樞神經系統（CNS）研究
  • 發炎研究
  • 代謝研究
  • 呼吸研究
  • 其他用途

第8章 全球G 蛋白偶聯受體 (GPCR) 市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abcam PLC
  • Accure Pharma
  • Actelion
  • Addex Pharmaceuticals Ltd
  • Arena Pharmaceuticals, Inc.
  • BD（Becton, Dickinson and Company）
  • BioInvenu, Inc.
  • Cisbio Bioassays
  • Corning Incorporated
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX
  • HD Biosciences Co., Ltd
  • Merck Group
  • Molecular Devices, LLC.
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen
  • Thermo Fisher Scientific
  • WuXi AppTec
  • Confo Therapeutics
Product Code: SMRC24068

According to Stratistics MRC, the Global G-Protein Coupled Receptors (GPCRs) Market is accounted for $3.70 billion in 2023 and is expected to reach $5.98 billion by 2030 growing at a CAGR of 7.1% during the forecast period. The diverse group of membrane receptors known as G-Protein Coupled Receptors (GPCRs), also referred to as seven-(pass)-trans membrane receptors. These can be found in the cell membrane and are in charge of interacting with external chemicals and relaying signals to intracellular molecules. GPCRs are cell surface receptors that function as an inbox for messages delivered as peptides, proteins, light energy, lipids, and sugars. These receptors are frequently employed in the management of a wide range of illnesses, including inflammatory disorders, metabolic disturbances, cardiac disorders, cancer, and monogenic disorders.

According to the American Heart Association's 2021 Journal, more than 130 million adults in the United States are expected to have some type of heart disease by 2035.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

The increasing prevalence of chronic diseases serves as a robust driver in the G-Protein Coupled Receptors (GPCRs) market. GPCRs play a pivotal role in regulating numerous physiological processes, making them valuable drug targets. With a growing global burden of chronic conditions such as diabetes, cardiovascular diseases, and neurodegenerative disorders, the demand for pharmaceutical interventions that target GPCRs is on the rise. Researchers are exploring GPCRs for innovative therapeutic solutions, which has stimulated research and development in the pharmaceutical industry.

Restraint:

High cost of G-protein coupled receptors (GPCRs) cell lines

The high price of G-Protein Coupled Receptors (GPCRs) cell lines represents a significant restraint in the GPCR market. The substantial cost associated with acquiring these cell lines can be prohibitive for smaller research institutions and biotech startups, limiting their ability to engage in GPCR-related research and drug development. This pricing barrier can stifle innovation, reduce competition, and impede scientific progress in understanding and targeting GPCRs, potentially slowing down the discovery of new pharmaceuticals.

Opportunity:

Adoption of GPCRs in drug discovery across the world

The widespread adoption of G-Protein Coupled Receptors (GPCRs) in drug discovery represents a significant opportunity for the market. GPCRs are a diverse class of drug targets involved in regulating various physiological processes, making them crucial for pharmaceutical research. Their versatility and involvement in numerous diseases, including cancer, neurological disorders, and metabolic conditions, have led to increased interest. As drug discovery efforts become increasingly globalized, GPCRs offer a promising avenue for innovative drug development. This adoption of GPCRs as targets for new therapeutics enhances research and development initiatives, paving the way for novel medications, and underscores the substantial growth potential in the GPCR market on a global scale.

Threat:

Complexity of the GPCR signalling system

The family of cell surface receptors known as GPCRs includes many different types of receptors and has complex signaling systems. It can be difficult to comprehend how they interact with different ligands and downstream signaling cascades, which makes it more difficult to find new drugs and develop existing ones. Because of this complexity, it is harder to predict a drug candidate's effectiveness, and there is a higher risk of unanticipated negative effects. Additionally, a lot of research, cutting-edge technology, and collaboration are needed, which are expensive and time-consuming. All of these elements are expected to restrain market growth.

COVID-19 Impact:

The G-Protein Coupled Receptors (GPCR) market has been significantly impacted by the COVID-19 pandemic in a number of ways. Lab closures and resource redistribution towards pandemic-related studies resulted in a slowdown in the study of GPCRs, which are essential for drug discovery. On the other hand, it has hastened the adoption of computational and virtual screening techniques for GPCR drug development. Due to the role that GPCRs play in immune responses and the potential they provide for treating viral infections, the market saw an increase in demand for GPCR-targeted therapies. Overall, the pandemic affected the GPCR market by fostering innovation and stifling it with a move toward digital methods.

The cAMP functional assays segment is expected to be the largest during the forecast period

The cAMP functional assays segment is anticipated to register the largest market share in the anticipated timeframe. This is due to its critical role in drug discovery and understanding cellular signaling. cAMP assays are widely utilized for studying GPCR activation and signaling pathways, making them integral to identifying potential drug candidates. They enable researchers to assess GPCR responses to ligands, providing valuable insights into drug efficacy and safety. With the rising demand for GPCR-targeted drugs, cAMP assays have gained prominence, driving their dominance in the market.

The cancer research segment is expected to have the highest CAGR during the forecast period

The cancer research segment is experiencing the highest growth rate during the forecast period due to the pivotal role GPCRs play in cancer progression. Research has revealed GPCRs' involvement in tumor growth, angiogenesis, and metastasis, making them attractive targets for cancer therapy. Additionally, the market's growth is fueled by the increased emphasis on personalized medicine and the development of GPCR-targeted cancer drugs. Advances in understanding GPCR signaling in cancer have led to a surge in innovative therapies and a growing demand for GPCR-related research tools, positioning this segment for substantial expansion in the near future.

Region with largest share:

During the forecast period, North America is anticipated to witness largest market share, led by the economically and technologically developed nations of the United States, Canada, and Mexico. According to the American Cancer Society, there will be 1.9 million new cases of cancer and 609,360 cancer-related deaths in the United States alone in 2022. In a similar vein, the Canadian Cancer Statistics 2021 revealed that roughly 2 in 5 Canadians will receive a cancer diagnosis during their lifetime and that 1 in 4 will pass away from the disease. Further bolstering market growth in North America is the burden of chronic diseases, particularly in cardiovascular and cancer applications, which is raising demand for cutting-edge therapies and treatments.

Region with highest CAGR:

Asia-Pacific is expected to experience the highest growth during the forecast period due to the presence of a number of young businesses like NB Health Laboratory, HD Biosciences Co., Ltd., and Sosei Heptares. Regional growth is influenced by the number of initiatives companies take to enhance their market presence. Furthermore, regional expansion is also fueled by the growing prevalence of lifestyle disorders among the expanding populations of China, India, and other economies, as well as the need to treat them with receptors.

Key players in the market:

Some of the key players in G-Protein Coupled Receptors (GPCRs) market include: Abcam PLC, Accure Pharma, Actelion, Addex Pharmaceuticals Ltd, Arena Pharmaceuticals, Inc., BD (Becton, Dickinson and Company), BioInvenu, Inc., Cisbio Bioassays, Corning Incorporated, Enzo Life Sciences, Inc., Eurofins DiscoverX, HD Biosciences Co., Ltd, Merck Group, Molecular Devices, LLC., PerkinElmer Inc., Promega Corporation, Qiagen, Thermo Fisher Scientific WuXi AppTec and Confo Therapeutics.

Key Developments:

In March 2023, Confo Therapeutics, a leader in targeting G-Protein Coupled Receptors (GPCRs) (GPCRs), this week announced an agreement with Daiichi Sankyo for the discovery and development of small molecule agonists against an undisclosed CNS target. Confo will receive upfront and milestone payments totaling $183 million and tiered royalties on sales from any resulting products.

In December 2022, Sosei Group Corporation announced its partnership with Eli Lilly and Company, a global biopharmaceutical firm. The collaboration aims to facilitate drug discovery for novel G protein-coupled receptor (GPCR) targets linked to diabetes and metabolic diseases, including the development and commercialization of small molecules with therapeutic potential.

In April 2022, Ono Pharmaceutical Co., Ltd. signed a new collaboration agreement with Domain Therapeutics and Universite de Montreal to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs) (GPCRs) in a metabolic disease area.

Products Covered:

  • Cell Culture Reagents
  • Cell Lines
  • Detection Kits
  • Ligands

Assay Types Covered:

  • cAMP Functional Assays
  • Calcium Functional Assays
  • Internalization Assays
  • Radioligand Binding and GTPγS Functional Assays
  • Trafficking Assays
  • B-Arrestin Functional Assays
  • Other Assay Types

Applications Covered:

  • Cancer Research
  • Cardiovascular Research
  • Central Nervous System (CNS) Research
  • Inflammation Research
  • Metabolic Research
  • Respiratory Research
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global G-Protein Coupled Receptors (GPCRs) Market, By Product

  • 5.1 Introduction
  • 5.2 Cell Culture Reagents
  • 5.3 Cell Lines
  • 5.4 Detection Kits
  • 5.5 Ligands

6 Global G-Protein Coupled Receptors (GPCRs) Market, By Assay Type

  • 6.1 Introduction
  • 6.2 cAMP Functional Assays
  • 6.3 Calcium Functional Assays
  • 6.4 Internalization Assays
  • 6.5 Radioligand Binding and GTPγS Functional Assays
  • 6.6 Trafficking Assays
  • 6.7 B-Arrestin Functional Assays
  • 6.8 Other Assay Types

7 Global G-Protein Coupled Receptors (GPCRs) Market, By Application

  • 7.1 Introduction
  • 7.2 Cancer Research
  • 7.3 Cardiovascular Research
  • 7.4 Central Nervous System (CNS) Research
  • 7.5 Inflammation Research
  • 7.6 Metabolic Research
  • 7.7 Respiratory Research
  • 7.8 Other Applications

8 Global G-Protein Coupled Receptors (GPCRs) Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abcam PLC
  • 10.2 Accure Pharma
  • 10.3 Actelion
  • 10.4 Addex Pharmaceuticals Ltd
  • 10.5 Arena Pharmaceuticals, Inc.
  • 10.6 BD (Becton, Dickinson and Company)
  • 10.7 BioInvenu, Inc.
  • 10.8 Cisbio Bioassays
  • 10.9 Corning Incorporated
  • 10.10 Enzo Life Sciences, Inc.
  • 10.11 Eurofins DiscoverX
  • 10.12 HD Biosciences Co., Ltd
  • 10.13 Merck Group
  • 10.14 Molecular Devices, LLC.
  • 10.15 PerkinElmer Inc.
  • 10.16 Promega Corporation
  • 10.17 Qiagen
  • 10.18 Thermo Fisher Scientific
  • 10.19 WuXi AppTec
  • 10.20 Confo Therapeutics

List of Tables

  • Table 1 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
  • Table 4 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
  • Table 5 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
  • Table 6 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
  • Table 7 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
  • Table 8 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
  • Table 9 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
  • Table 10 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
  • Table 11 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTPγS Functional Assays (2021-2030) ($MN)
  • Table 12 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
  • Table 13 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By B-Arrestin Functional Assays (2021-2030) ($MN)
  • Table 14 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
  • Table 15 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
  • Table 17 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
  • Table 18 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
  • Table 19 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
  • Table 21 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
  • Table 22 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
  • Table 23 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 24 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
  • Table 26 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
  • Table 27 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
  • Table 28 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
  • Table 29 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
  • Table 30 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
  • Table 31 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
  • Table 32 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
  • Table 33 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
  • Table 34 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTPγS Functional Assays (2021-2030) ($MN)
  • Table 35 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
  • Table 36 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By B-Arrestin Functional Assays (2021-2030) ($MN)
  • Table 37 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
  • Table 38 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
  • Table 39 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
  • Table 40 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
  • Table 41 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
  • Table 42 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
  • Table 44 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
  • Table 45 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
  • Table 46 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 47 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
  • Table 49 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
  • Table 50 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
  • Table 51 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
  • Table 52 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
  • Table 53 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
  • Table 54 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
  • Table 55 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
  • Table 56 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
  • Table 57 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTPγS Functional Assays (2021-2030) ($MN)
  • Table 58 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
  • Table 59 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By B-Arrestin Functional Assays (2021-2030) ($MN)
  • Table 60 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
  • Table 61 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
  • Table 62 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
  • Table 63 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
  • Table 64 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
  • Table 65 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
  • Table 67 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
  • Table 68 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
  • Table 69 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 70 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
  • Table 72 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
  • Table 73 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
  • Table 74 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
  • Table 75 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
  • Table 76 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
  • Table 77 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
  • Table 78 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
  • Table 79 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
  • Table 80 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTPγS Functional Assays (2021-2030) ($MN)
  • Table 81 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
  • Table 82 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By B-Arrestin Functional Assays (2021-2030) ($MN)
  • Table 83 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
  • Table 84 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
  • Table 85 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
  • Table 86 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
  • Table 87 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
  • Table 88 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
  • Table 90 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
  • Table 91 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
  • Table 92 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 93 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
  • Table 95 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
  • Table 96 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
  • Table 97 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
  • Table 98 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
  • Table 99 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
  • Table 100 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
  • Table 101 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
  • Table 102 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
  • Table 103 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTPγS Functional Assays (2021-2030) ($MN)
  • Table 104 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
  • Table 105 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By B-Arrestin Functional Assays (2021-2030) ($MN)
  • Table 106 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
  • Table 107 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
  • Table 108 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
  • Table 109 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
  • Table 110 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
  • Table 111 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
  • Table 113 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
  • Table 114 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
  • Table 115 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 116 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
  • Table 118 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
  • Table 119 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
  • Table 120 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
  • Table 121 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
  • Table 122 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
  • Table 123 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
  • Table 124 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
  • Table 125 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
  • Table 126 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTPγS Functional Assays (2021-2030) ($MN)
  • Table 127 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
  • Table 128 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By B-Arrestin Functional Assays (2021-2030) ($MN)
  • Table 129 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
  • Table 130 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
  • Table 131 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
  • Table 132 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
  • Table 133 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
  • Table 134 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
  • Table 136 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
  • Table 137 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
  • Table 138 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)